Fire-service OTC · Adult & pediatric scope · FS-ARN

Bacitracin ointment

10-second priorities

FS-ARN
Start here
FS-ARN program scope only; this is not a general ALS/BLS administration order.
Do not miss
Check known allergy and the exact product’s current label.
Next decision
No pediatric 9-1-1 regimen is supplied by SO-F-02.

Priority checkpoints. Full criteria, doses and exceptions below.

Topical bacitracin listed in the FS-ARN OTC program.

OCEMS source summary · Updated 2026-09-30

Safety sections checked September 30, 2026 · verified with limits. Existing numeric regimens retain their original source context.

FIELD REFERENCE

Full criteria & treatment guidance

Indications

  • First aid to help prevent infection in minor cuts, scrapes and burns, for the cited bacitracin ointment.

Contraindications & local exclusions

  • The ointment label excludes ingredient allergy, eye use, application over large body areas, and use longer than 1 week without medical direction.

Precautions

  • External use only. Deep/puncture wounds, animal bites or serious burns need medical advice; ingestion requires help. This ointment label does not cover injectable bacitracin.
  • These are selected safety checks, not a complete prescribing monograph. Product labeling and OCEMS authorization answer different questions; confirm the actual product, patient population and applicable order.

Scope & authority

  • FS-ARN scope only; this listing is not a general ALS/BLS administration order.
  • SO-F-02 supplies no pediatric field regimen.

Adult / adolescent

  • SO-F-02 permits an authorized Fire Service RN to maintain this listed OTC product/category while functioning in the fire-service role. It is made available to firefighting personnel without a known allergy to the product.
  • Use this medication only for the indications and doses printed on its container. OCEMS does not publish a universal dose for this product. Eligible personnel must obtain the medication from its container without assistance.

Pediatric

  • SO-F-02 applies to adult and adolescent fire-service personnel. It does not authorize pediatric 9-1-1 dosing, and this page does not add consumer pediatric doses.
  • Do not convert a package’s consumer pediatric directions into OCEMS field authority. Use an applicable pediatric standing order or medical direction for a child requiring care.

Pediatric dosing availability

  • SO-F-02 supplies no pediatric 9-1-1 dosing or administration authority. This page does not add consumer pediatric doses.
Pediatric dosing availability
WeightOCEMS pediatric dose
Any weightNo general OCEMS pediatric dose is listed; follow the applicable order or medical direction.

Use, monitoring & documentation

  • Identify the exact product, active ingredients, strength, and label before use; products in a named OTC category can have different formulations.
  • Follow the product’s labeled indications, exclusions, dose, and interval within the authorized program. The absence of an EMS numerical dose here is intentional: SO-F-02 delegates those details to the product label.

UNDERSTAND THE CARE

Check the actual topical preparation

Identify the selected ointment and ingredients and compare the intended use with its current label. A familiar topical-antibiotic name does not establish that every formulation or combination has the same instructions. Include known allergy in the local program check. The linked OCEMS document establishes the program context; a product-specific label answers a different question about the selected preparation.

Teaching diagram: Program: Eligible FS-ARN setting and personnel.; Identity: Exact product, ingredients and formulation.; Label: Current directions, allergy and exclusions.; Record: Product and actual amount; no invented pediatric regimen.
Bacitracin ointment assessment map. A teaching map of the linked guidance; it is not a complete treatment algorithm.

Applying the guidance

Confirm that the person and setting fit the FS-ARN program before using the supply listing. Then reconcile the container, ingredients, strength, route and label with the intended use and document what was actually used. If the exact product is not established, retain that uncertainty rather than filling the gap with a consumer dose from another formulation. The pediatric limitation remains explicit.

Diagram text & teaching checkpoints

Program
Eligible FS-ARN setting and personnel.
Identity
Exact product, ingredients and formulation.
Label
Current directions, allergy and exclusions.
Record
Product and actual amount; no invented pediatric regimen.

Sources for this explanation

Original OCMedic teaching synthesis of the references below. Educational expansion updated ; this is not a new independent clinical-review date. Source-specific dates and limitations remain in the full guidance.

About OCMedic · Editorial approach & corrections

Distinguish a minor-wound product from the wound assessment

The cited label is for a topical bacitracin ointment intended for minor cuts, scrapes and burns. It does not cover every wound that could become infected. Deep or puncture wounds, animal bites and serious burns are specifically reasons to obtain medical advice under that label.

When explaining what was used, name the actual ointment and whether it was a single-ingredient or different preparation. The familiar word “antibiotic” does not identify the container or the ingredients relevant to an allergy history. The existing label exclusions—such as eye use, large-area application and prolonged use without direction—remain separate from whether the person and setting fit the FS-ARN program.

A wound that needs assessment should not be summarized only as “ointment applied.” Describe the wound and the reason for any escalation alongside the product history. The topical label supports these safety checks; it does not create a general EMS administration order or a pediatric field regimen.

Sources: SO-F-02 · Product label

Explore this guide

Related guides

Drug label / general safety

Checked September 30, 2026. Research verification is not independent clinical review.

Product labelBACITRACIN ointment ↗

OCEMS sources

See linked source for document dates and scope restrictions.
Source checked September 16, 2026.
Summary updated 2026-09-30.

SO-F-02Over the Counter (OTC) Medications ↗

This summary does not replace the complete policy, current system notices, or clinical judgment.

Independent OCMedic summary. Open cited source ↗ Sources, review limits & corrections

Browse the field reference

Back to top